Corona virus 2019 like illness and public adherence to preventive measures, Sudan 2020
pdf

Keywords

Key words: COVID_19, protective measures, suspected, screening.

Abstract

Introduction: In December 2019, a novel corona virus disease was identified and was responsible for the new cases of respiratory tract infections in Wuhan, China. This virus was responsible for the pandemic with more than 84 million cases and 1.82 million deaths worldwide. In Sudan till now the reported cases exceed 23,000 with 1.400 deaths. This study aims to determine the prevalence of COVID_19 suspected cases, health seeking behavior and public adherence to protective measures.

Methods: Descriptive community based cross sectional study, conducted in Khartoum state 2020. 3499 respondents with diverse socio-demographic backgrounds were finally enrolled in the study. Data was collected through Manitoba Corona Virus 2019 screening form which distributed through online anonymous Google forms. Data was entered and analyzed by Statistical Package of Social Sciences version 23.

Results: The study revealed that 26.5% of the respondents were clinically suspected. with headache or fatigability being the most common symptom followed by pharyngitis and then dry cough.  Asthma and chronic respiratory disease as the commonest comorbidities. Wearing facial masks and regular hand washing were found to be the most used protective measures with only 39.4% implicates social distancing in their daily life. Health seeking behavior was significantly different among suspected respondents the majority tend to use antibiotics than to isolate themselves or undergo testing.

Conclusion: COVID_19 suspected cases were prevalent among Sudanese population, screening capacity has to be increased with more strong policies for implications of personal protective measures in the daily life.

 

 

https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1988
pdf

References

(1)WHO Director-(2)General’s opening remarks at the media briefing on COVID19 -March 2020
(2)CIDRAP-Center for Infectious Disease Research and Policy. 11 March 2020
(3) Woelfel R, Corman VM, Guggemos W, et al. Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster. medRXiv. March,8, 2020
(4) Srinivas M, Gomersall CD, Fowler R. Critically Ill Patients With COVID-19 JAMA. Published online. March 11, 2020 doi:10.1001/JAMA.2020.3633
(5)Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. [PMID: 31986264] doi:10.1016/S0140-6736(20)30183.
(6) Who.int. 2020. [online] Available at: [Accessed 29 November 2020]
(7)Doi.org. 2020. Redirecting. [online] Available at: [Accessed 29 November 2020].
(8)Manitoba screening tool. https://sharedhealthmb.ca/covid19/screening.tool/
(9)SAGE Journals. 2020. Clinical Presentation Of COVID-19: A Systematic Review Focusing On Upper Airway Symptoms - Andrea Lovato, Cosimo De Filippis, 2020. [online] Available at: [Accessed 30 November 2020].
(10)Medrxiv.org. 2020. [online] Available at: [Accessed 30 November 2020].
(11)Medrxiv.org. 2020. [online] Available at: [Accessed 30 November 2020].
(12)Menni, C., Valdes, A., Freidin, M., Sudre, C., Nguyen, L., Drew, D., Ganesh, S., Varsavsky, T., Cardoso, M., El-SayedMoustafa, J., Visconti, A., Hysi, P., Bowyer, R., Mangino, M., Falchi, M., Wolf, J., Ourselin, S., Chan, A., Steves, C. and Spector, T., 2020. Real-Time Tracking Of Self-Reported Symptoms To Predict Potential COVID-19.
(13)Zens, M., Brammertz, A., Herpich, J., Südkamp, N. and Hinterseer, M., 2020. App-Based Tracking Of Self-Reported COVID-19 Symptoms: Analysis Of Questionnaire Data.
(14)PMC, E., 2020. Europe PMC. [online] Europepmc.org. Available a [Accessed 30 November 2020]. - Xiao J, Shiu EYC, Gao H, et al. Nonpharmaceutical measures for pandemic
(15)-Hamad S Alyami, Mohamed AA Orabi, Fahad M Aldhabbah, Hamad N Alturki, Wejdan I Aburas, Abdulrahman I Alfayez, Abdullah S Alharbi, Rawan A Almasuood, Njood A Alsuhaibani
Saudi Pharmaceutical Journal 28 (11), 1326-1332, 2020.
(16)- influenza in nonhealthcare settings-personal protective and environmental measures. Emerg Infect Dis 2020; 26. Available from: https://wwwnc.cdc.gov/eid/article/ 26/5/19-0994_article.
Google Scholar
(17)-M. Machida et al. / International Journal of Infectious Diseases 94 (2020) 139–144.
(18)-Abdulrahman S Bazaid, Abdu Aldarhami, Naif K Binsaleh, SubuhiSherwani, Omar W Althomali
PloS one 15 (12), e0243695, 2020.
(19)-Int. J. Environ. Res. Public Health, EISSN 1660-4601, Published by MDPI.
(20)-https://doi.org/10.1016/j.ijid.2020.03.017
(21)-Jing Yang, YaZheng, Xi Gou, KePu, Zhaofeng Chen, QinghongGuo, RuiJi, Haojia Wang, Yuping Wang, Yongning Zhou International journal of infectious diseases, 2020.
(22)-Jixiang Zhang, Xiaoli Wang, XuemeiJia, Jiao Li, Ke Hu, Guozhong Chen, Jie Wei, Zuojiong Gong, Chenliang Zhou, Hongang Yu, Mosheng Yu, Hongbo Lei, Fan Cheng, Binghong Zhang, Yu Xu, Gaohua Wang, Weiguo Dong
Clinical Microbiology and Infection, 2020.